akinbostanci/iStock via Getty Images
ZimVie (NASDAQ:ZIMV) may be worth $25-$29 a share in a potential takeover, according to a Needham analyst, after a report earlier Tuesday that the dental implants maker is weighing a potential sale amid acquisition interest.
The company could be a target for strategic players or private equity firms, Needham analyst David Saxon wrote in a note on Tuesday.
Other strategic players that could be interested include Dentsply Sirona (XRAY), Envista (NVST), Henry Schein (HSIC) and Straumann (OTCPK:SAUHF), though they may encounter antitrust issues, according to Saxon. He sees Envista as the least likely strategic who could be interested in ZimVie (ZIMV).
ZimVie (ZIMV) shares surged 23% on Tuesday in the wake of the Bloomberg report of a potential sale.